Houston, TX -- (SBWIRE) -- 12/10/2012 -- MAKO Surgical Corp. (NASDAQ:MAKO) is currently trading at $13.65, 6.77% higher. MAKO Surgical Corp. (MAKO) is a medical device company that markets its robotic arm solution and orthopedic implants for orthopedic procedures called MAKOplasty. The Company offers MAKOplasty, a surgical solution that enables orthopedic surgeons to treat patient specific, osteoarthritic disease. MAKOplasty is performed using its RIO Robotic Arm Interactive Orthopedic system (RIO).
How Should Investors Trade MAKO After The Recent Volatile Moves? Find Out click my link
Volcano Corporation (NASDAQ:VOLC) added 0.47% to $23.76. Volcano Corporation (Volcano) designs, develops, manufactures and commercializes a range of precision guided therapy tools, including intravascular ultrasound (IVUS), and fractional flow reserve (FFR), products. The Company is facilitating the adoption of functional percutaneous interventional (PCI), in which its FFR technology is used to determine whether or not a stent is necessary, and IVUS is used to guide stent placement and optimization.
Is VOLC Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis click my link
Orexigen Therapeutics, Inc. (NASDAQ:OREX) is higher 1.53% to $5.31. Orexigen Therapeutics, Inc. develops drug treatments for obesity and related disorders. Orexigen Therapeutics, Inc. develops and commercializes combinations of currently available drugs that are designed to achieve and sustain weight loss by enhancing satiety, diminishing appetite, improving energy expenditure and minimizing the body's efforts to compensate for weight loss.
Can OREX Rebound After The Recent Slump and Investors Can Make Money? Find Out click my link
Sequenom, Inc. (NASDAQ:SQNM) among the gainers and the stock added 6.03% to $4.92. Manufactures DNA detection and sequencing equipment. The Company's two business units combine to utilize their MassARRAY system, SNP assay portfolio, disease gene discovery programs and DNA sample repository. Sequenom provides genetic analysis products that translate genomic science into solutions for biomedical research, molecular medicine and agricultural applications.
Is SQNM Ready To Move Back To New Highs This Year? Find Out click my link
NPS Pharmaceuticals, Inc. (NASDAQ:NPSP) is lower 2.06% to $9.50. NPS Pharmaceuticals, Inc. (NPS) is a clinical-stage biopharmaceutical company. The Company is focused on the development of orphan products for patients with rare gastrointestinal and endocrine disorders and high unmet medical needs. NPS clinical programs involve two therapeutic peptides to restore or replace biological function: Gattex (teduglutide) and Natpara. Teduglude, its analog of GLP-2, a protein involved in the regeneration and repair of the intestinal lining.
Is NPSP Showing Any Sign of Buy At The Current Market Price? Get Our Free Trend Analysis click my link
Information, opinions and analysis contained herein are based on sources believed to be reliable, but no representation, expressed or implied, is made as to its accuracy, completeness or correctness. The opinions contained herein reflect our current judgment and are subject to change without notice. We accept no liability for any losses arising from an investor’s reliance on or use of this report. This report is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. A third party has hired and paid IO News Wire twelve hundred and ninety five dollars for the publication and circulation of this news release. Certain information included herein is forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995, including, but not limited to, statements concerning manufacturing, marketing, growth, and expansion. Such forward-looking information involves important risks and uncertainties that could affect actual results and cause them to differ materially from expectations expressed herein. We have no ownership of equity, no representation; do no trading of any kind and send no faxes or emails.
Winning Media LLC
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)